English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Review article
2023
Authors:  Chang, Jane Pei Chen;  Tseng, Ping Tao;  Zeng, Bing Syuan;  Chang, Cheng Ho;  Su, Huanxing; et al.
Favorite | TC[WOS]:14 TC[Scopus]:17  IF:8.0/10.6 | Submit date：2024/01/10
Adverse Effect  Docosahexaenoic Acid (Dha)  Eicosapentaenoid Acid (Epa)  Prescription Ω-3 Pufa Products (Rxome3fas)  Tolerability  Ω-3 Polyunsaturated Fatty Acids (Pufas)  
Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials Journal article
Zhang, Xin, Ritonja, Jennifer A., Zhou, Na, Chen, Bingshu E., Li, Xinzhi. Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials[J]. Journal of the American Heart Association, 2022, 11(11).
Authors:  Zhang, Xin;  Ritonja, Jennifer A.;  Zhou, Na;  Chen, Bingshu E.;  Li, Xinzhi
Favorite | TC[WOS]:44 TC[Scopus]:55  IF:5.0/5.7 | Submit date：2023/01/30
1-stage Regression  Docosahexaenoic Acid  Eicosapentaenoic Acid  Hypertension  Long-chain Fatty Acids  
Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder Journal article
Yang B., Lin L., Bazinet R.P., Chien Y.-C., Chang J.P.-C., Satyanarayanan S.K., Su H., Su K.-P.. Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder[J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2019, 88(4), 215-224.
Authors:  Yang B.;  Lin L.;  Bazinet R.P.;  Chien Y.-C.;  Chang J.P.-C.; et al.
Favorite | TC[WOS]:35 TC[Scopus]:37  IF:16.3/17.5 | Submit date：2020/04/20
Docosahexaenoic Acid  Eicosapentaenoic Acid  Endocannabinoids  Major Depressive Disorder  Ω–3 Polyunsaturated Fatty Acid  
Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines Journal article
Huang L.-L., Wan J.-B., Wang B., He C.-W., Ma H., Li T.-W., Kang J.X.. Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines[J]. Prostaglandins Leukotrienes and Essential Fatty Acids, 2013, 88(5), 347-353.
Authors:  Huang L.-L.;  Wan J.-B.;  Wang B.;  He C.-W.;  Ma H.; et al.
Favorite | TC[WOS]:62 TC[Scopus]:67  IF:2.9/3.2 | Submit date：2018/10/30
Alcoholic Liver Disease  Hepatic Steatosis  Docosahexaenoic Acid  Stearoyl-coa Desaturase 1  Inflammatory Cytokines